S. Verselis

发表

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.

J. Garber, P. Wong, S. Verselis, 2006, Gastroenterology.

Novel p53 splice site mutations in three families with Li-Fraumeni syndrome

J. Fraumeni, S. Verselis, Frederick P. Li, 2000, Oncogene.

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

P. Miron, A. Richardson, R. Gelman, 2013, Breast Cancer Research and Treatment.

Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the Fc{gamma}RIIIa-158 V/V and V/F polymorphism.

K. Anderson, S. Verselis, E. Fox, 2007, Blood.

Carcinoembryonic antigen in breast nipple aspirate fluid.

D. Fairclough, J. Garber, L. Forétova, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Absence of germline p16 INK4a alterations in p53 wild type Li-Fraumeni syndrome families

C. Portwine, F. Li, D. Malkin, 2000, Journal of medical genetics.

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD AML

A. Lane, S. Verselis, K. Ballen, 2014 .

Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia.

A. Lane, S. Verselis, K. Ballen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prostate-specific antigen in nipple aspirate

L. Forétova, S. Verselis, Frederick P. Li, 1996, The Lancet.

Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia

S. Verselis, E. Fox, S. Treon, 2009, British journal of haematology.

CD4+ T cell activation in multiple sclerosis

S. Verselis, J. Goust, 1987, Journal of Neuroimmunology.

p53 compound heterozygosity in a severely affected child with Li-Fraumeni Syndrome

C. Portwine, J. Garber, D. Malkin, 1999, Oncogene.

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.

E. Kimby, D. Maloney, M. Hansen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with FLT3-ITD AML

S. Verselis, K. Ballen, R. Soiffer, 2014 .

Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.

Barbara L. Smith, L. Forétova, C. Kaelin, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nipple F luid C arcinoembryonic A ntigen a nd P rostate- Specific A ntigen i n C ancer-Bearing a nd Tumor-Free B reasts

Barbara L. Smith, L. Forétova, C. Kaelin, 2001 .

AGenome-WideAberrantRNASplicing inPatientswithAcute MyeloidLeukemia IdentifiesNovelPotentialDiseaseMarkers and Therapeutic Targets

P. Pilarski, John Quackenbush, B. Haibe-Kains, 2014 .

A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets

P. Pilarski, John Quackenbush, B. Haibe-Kains, 2013, Clinical Cancer Research.

Gastric cancer in individuals with Li-Fraumeni syndrome

J. Fraumeni, J. Garber, L. Forétova, 2011, Genetics in Medicine.

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

K. Isselbacher, J. Fraumeni, D. Haber, 1999, Science.

Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer

P. Hammerman, R. Tishler, S. Verselis, 2017, Front. Oncol..

Molecular epidemiology study of a suspected community cluster of childhood cancers.

J. Fraumeni, S. Verselis, R. Hutchinson, 1997, Medical and pediatric oncology.

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

L. Pilarski, D. Dorfman, S. Verselis, 2023, Blood Cancer Journal.

Genetic Linkage of FcgγRIIa and FcγRIIIa and Implications for Their Use in Predicting Clinical Responses to CD20-Directed Monoclonal Antibody Therapy

M. Hansen, S. Verselis, E. Fox, 2007 .

Regulation of angiogenin expression in human HepG2 hepatoma cells by mediators of the acute-phase response.

S. Verselis, K. Olson, J. Fett, 1999, Biochemical and biophysical research communications.

Angiogenin is regulated in vivo as an acute phase protein.

S. Verselis, K. Olson, J. Fett, 1998, Biochemical and biophysical research communications.

Attainment of complete/very good partial response following rituximab‐based therapy is an important determinant to progression‐free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia

Hsiuyi Tseng, S. Verselis, E. Fox, 2011, British journal of haematology.

NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML.

P. Pilarski, John Quackenbush, Benjamin Haibe-Kains, 2014, Blood.

Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.

M. Hansen, S. Verselis, E. Fox, 2007, Clinical lymphoma & myeloma.

IgA and IgG Hypogammaglobulinemia Are Associated with Mutations in the APRIL/BLYS Receptor TACI in Waldenstrom’s Macroglobulinemia (WM).

S. Verselis, E. Fox, S. Treon, 2006 .

Polymorphisms in FcγRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenstrom's macroglobulinemia.

E. Kimby, K. Anderson, D. Maloney, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.